Mirai Medical, a Galway based cancer treatment start-up, is leading a consortium planning to invest €7.2 million in developing a better way to treat gastrointestinal cancer, as well as potentially treating all solid tumours. The company, founded by Dr Declan Soden, is leading a group that also includes Nasdaq listed Advanced Energy and three Irish universities – NUIG, UCC and Trinity in Dublin. About €4.78 million of the funding being invested in researching these new treatments was awarded last week under the state’s Disruptive Technology Innovation Fund (DTIF). This award will allow Mirai Medical to expand its ePORE platform a…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .